Immunomodulators Market Worth US$ 263.9 Billion by 2027 | Amgen Inc., Biogen Inc., Bristol-Myers Squibb Company

 According to the latest report by IMARC Group, titled “Immunomodulators Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, the global immunomodulators market size reached US$ 187.7 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 263.9 Billion by 2027, exhibiting a growth rate (CAGR) of 5.76% during 2022-2027.

Immunomodulators Market Size 2022-2027


Market Outlook:

Immunomodulators refer to a group of drugs that are commonly prescribed to modify an immune response against immunodeficiency, infectious diseases and alterations in antibody transfer. These medicines are used for the treatment of asthma, cancer, tumors and autoimmune disorders. Some of these drugs include cytokines, levamisole, monoclonal antibodies and Bacillus Calmette-Guerin (BCG).

Note: We are updating our reports, If you want the latest primary and secondary data (2023-2028) with Cost Module, Business Strategy, Competitive landscape, etc. Click request free sample report, the report will be delivered to you via email within 24 to 48 hours.

Download a free sample report to get a detailed overview of the market: https://www.imarcgroup.com/immunomodulators-market/requestsample

The global market is majorly driven by the increasing incidences of numerous chronic diseases among the masses. This can be attributed to the growing geriatric population, sedentary lifestyles led by individuals and their changing dietary preferences.

Additionally, there has been a considerable rise in the prevalence of severe road accidents, which has boosted the demand for immunomodulators as a crucial agent in organ transplant procedures.

Furthermore, multiple immunomodulators, including Tocilizumab, Fluvoxamine, and Baricitinib with Remdesivir, are widely being prescribed by healthcare professionals for the treatment of patients suffering from the coronavirus disease (COVID-19). The rapid outbreak of COVID-19 across the globe is providing an impetus to the market growth.

List of Key Companies Covered in this Market Report:

  • Amgen Inc.
  • Biogen Inc.
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • Hoffmann-La Roche AG
  • Johnson & Johnson
  • Merck & Co. Inc.
  • Novartis AG
  • Pfizer Inc.

Key Highlights of the Market Segmentation:

Based on Product:

  • Immunosuppressants
    • Antibodies
    • Calcineurin Inhibitors
    • Glucocorticoids
    • Antimetabolites
    • Others
  • Immunostimulants
    • Vaccines
    • Antibodies
    • Others

Based on Application:

  • Oncology
  • Respiratory
  • HIV
  • Others

Geographical Analysis:

  • North America: (United States, Canada)
  • Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America: (Brazil, Mexico, Others)
  • Middle East and Africa

Make inquiry before purchase of this report: https://www.imarcgroup.com/request?type=report&id=4055&flag=F

Key Highlights of the Report:

  • Market Performance (2016-2021)
  • Market Outlook (2022-2027)
  • Market Trends
  • Market Drivers and Success Factors
  • Impact of COVID-19
  • Value Chain Analysis
  • Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group

30 N Gould St Ste R

Sheridan, WY 82801 USA - Wyoming

Email: Sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

Americas: - +1 631 791 1145 | Africa and Europe: - +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Comments

Popular posts from this blog

Vertical Farming Market- High Investment in the Vertical Farming

CBD Oil Market Assess the Trends, Opportunities and Competition in the Market

Automotive HMI Market Opportunities, Trends, Growth Analysis | Forecast – 2030